NCT04578184

Brief Summary

In keratoconic eyes, the corneal epithelium shows a localized thinning over the cone that is surrounded by an annulus of epithelial thickening. It has been postulated that epithelial thickness mapping can be a sensitive tool for the keratoconus diagnosis. In keratoconus screening the 5 mm diameter of the corneal centrum may be sufficient while studies have shown that the cone apex is located in this area. Aim of this study is to assess agreement and repeatability of epithelial thickness measurements using two optical coherence tomography devices in healthy and keratoconus corneas. Secondary objective is to evaluate the differences between healthy and keratoconus eyes using epithelial thickness map data. This is a prospective monocentric study that includes patients divided into two groups: patients with keratoconus and a control group formed out of patients without corneal pathologies. For each patient only one eye will be included and corneal measurements will be performed, focused on the corneal epithelium thickness.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2020

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 30, 2020

Completed
8 days until next milestone

First Posted

Study publicly available on registry

October 8, 2020

Completed
7 days until next milestone

Study Start

First participant enrolled

October 15, 2020

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2021

Completed
28 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2021

Completed
Last Updated

October 12, 2020

Status Verified

October 1, 2020

Enrollment Period

4 months

First QC Date

September 30, 2020

Last Update Submit

October 7, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Agreement between two ss-OCT devices in corneal epithelial thickness measurements (LoA in micrometer)

    6 months

Secondary Outcomes (1)

  • Repeatability between two ss-OCT devices in corneal epithelial thickness measurements (determination of within-subject standard deviation and Coefficient of variation)

    6 months

Study Arms (2)

Epithelial thickness map evaluation in keratoconus patients

OTHER

Patients included in the study will be measured with the corneal acquisition mode, also allowing for epithelium thickness data, on each device without pupil dilatation Each patient will be measured three times with both devices. The corneal epithelial thickness will be measured as the distance between the air-tear and the epithelium-Bowman interfaces.

Diagnostic Test: Corneal epithelial thickness measurements

Epithelial thickness map evaluation in healthy cornea patients

OTHER

Patients included in the study will be measured with the corneal acquisition mode, also allowing for epithelium thickness data, on each device without pupil dilatation Each patient will be measured three times with both devices. The corneal epithelial thickness will be measured as the distance between the air-tear and the epithelium-Bowman interfaces.

Diagnostic Test: Corneal epithelial thickness measurements

Interventions

Corneal epithelial thickness measurements using two optical coherence tomography devices in healthy and keratoconus corneas.

Epithelial thickness map evaluation in healthy cornea patientsEpithelial thickness map evaluation in keratoconus patients

Eligibility Criteria

Age21 Years - 100 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient with diagnosed keratoconus (diagnosed using tomography and topography map changes and slit-lamp changes) and patients with healthy cornea
  • Age 21 and older
  • Signed informed consent

You may not qualify if:

  • Previous ocular surgery
  • Associated corneal pathologies (e.g. trauma, edema, scarring)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hanusch Hospital, Ophthalmology Department

Vienna, 1140, Austria

RECRUITING

MeSH Terms

Conditions

Keratoconus

Condition Hierarchy (Ancestors)

Corneal DiseasesEye Diseases

Study Officials

  • Oliver Findl, Prof., MD

    Head of Department of Ophthalmology, Professor, Principal Investigator

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Oliver Findl, Prof., MD

CONTACT

Nino Hirnschall, MD, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of Department of Ophthalmology, Professor, Principal Investigator, MBA

Study Record Dates

First Submitted

September 30, 2020

First Posted

October 8, 2020

Study Start

October 15, 2020

Primary Completion

February 1, 2021

Study Completion

March 1, 2021

Last Updated

October 12, 2020

Record last verified: 2020-10

Data Sharing

IPD Sharing
Will not share

Locations